NexImmune, Inc. (NEXI)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Mar 25, 2026, 9:30 AM EST
NexImmune Market Cap
NexImmune has a market cap or net worth of $418 as of March 26, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
418.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 418.00, a decrease of -100.00%. That is a compound annual growth rate of -93.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 418.00 | 41,700.00% |
| Dec 31, 2025 | 1.00 | -100.00% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pathfinder Cell Therapy | 667.00 |
| Nabriva Therapeutics | 646.00 |
| Amarantus BioScience Holdings | 630.00 |
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |
| Mera Pharmaceuticals | 537.00 |
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |